Tumor Mutational Burden (TMB) in Immune Checkpoint Inhibitor (Ici)-Naïve and -Experienced Patients with Metastatic Melanoma Treated with Lifileucel, a Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy.
JOURNAL OF CLINICAL ONCOLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined